News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Seymour Albert
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/27/2023 |
4
| Seymour Albert (See Remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 632,000 options to buy
@ $1.6, valued at
$1M
Granted 105,000 restricted stock units
@ $0 |
|
| 01/11/2023 |
4
| Seymour Albert (See Remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 3,620 shares
@ $1.3904, valued at
$5k
|
|
| 01/04/2023 |
4
| Seymour Albert (See Remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Exercised 4,290 restricted stock units
@ $0
Exercised 6,930 restricted stock units
@ $0 |
|
| 09/08/2022 |
4
| Seymour Albert (See remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 23,000 options to buy
@ $2.18, valued at
$50.1k
Granted 14,000 restricted stock units
@ $0 |
|
| 04/21/2022 |
4
| Seymour Albert (See Remarks) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 60,000 options to buy
@ $1.78, valued at
$106.8k
|
|
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2022 |
4
| Seymour Albert (Chief Scientific Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 1,661 shares
@ $3.7801, valued at
$6.3k
Exercised 4,290 restricted stock units
@ $0 |
|
| 02/09/2021 |
4
| Seymour Albert (Chief Scientific Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 78,000 options to buy
@ $13.78, valued at
$1.1M
Granted 13,000 restricted stock units
@ $0 |
|
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2019 |
4
| Seymour Albert (Chief Scientific Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 110,000 options to buy
@ $19.92, valued at
$2.2M
|
|
| 12/03/2019 |
4
| Seymour Albert (Chief Scientific Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 9,300 shares
@ $16.0634, valued at
$149.4k
Sold 9,300 shares
@ $16.2333, valued at
$151k
|
|
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/05/2019 |
4
| Seymour Albert (Chief Scientific Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 9,300 shares
@ $18.7402, valued at
$174.3k
|
|
| 08/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2019 |
4
| Seymour Albert (Chief Scientific Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 9,200 shares
@ $18.9764, valued at
$174.6k
Sold 100 shares
@ $19.56, valued at
$2k
|
|
| 06/05/2019 |
4
| Seymour Albert (Chief Scientific Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 9,300 shares
@ $19.9025, valued at
$185.1k
|
|
| 12/18/2018 |
4
| Seymour Albert (Chief Scientific Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 74,000 options to buy
@ $24.28, valued at
$1.8M
|
|
| 03/29/2018 |
4
| Seymour Albert (Chief Scientific Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 66,501 options to buy
@ $16, valued at
$1.1M
|
|
|
|